| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $919K | -64.6% | +37.4% |
| Cost of Revenue | $1.1M | -8.7% | +929.4% |
| Gross Profit | -$185K | -113.3% | -130.4% |
| R&D Expense | $132K | +0.6% | +110.3% |
| SG&A Expense | $1.5M | +119.6% | +45.4% |
| Operating Income | -$3.2M | -234.2% | -88.6% |
| Pre-tax Income | -$4.7M | -162.5% | -186.5% |
| Net Income | -$4.7M | -162.5% | -186.5% |
| EPS (Basic) | -$0.27 | -125.0% | -107.7% |
| EPS (Diluted) | -$0.27 | -125.0% | -107.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.6M | +4515.9% | +70.8% |
| Accounts Receivable | $385K | -56.1% | — |
| Inventory | $2.1M | +45.3% | +17.2% |
| Current Assets | $6.8M | +103.5% | +42.8% |
| Total Assets | $17.5M | +16.9% | +64.4% |
| Current Liabilities | $9.2M | +44.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Investing Cash Flow | -$23K | — | — |
| Financing Cash Flow | $4.5M | — | — |
| +932.3% |
| Total Liabilities | $13.4M | +26.0% | +1332.0% |
| Stockholders' Equity | $4.1M | -5.5% | -57.7% |